Physician profile
Joan E Griffin
NPI 1689042046
$2,243.33
in general payments reported to CMS, 2019-2025
11 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $485 · 2022: $741 · 2023: $390 · 2024: $285 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,017.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,038.09 | 2022-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $443.10 | 2021-2025 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $200.52 | 2022-2025 | Zepbound |
| Tandem Diabetes Care, INC. | $172.47 | 2021-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $126.36 | 2021-2022 | |
| Medtronic, INC. | $78.88 | 2021 | |
| Currax Pharmaceuticals LLC | $61.35 | 2021 | |
| Mannkind Corporation | $50.00 | 2021 | |
| Novo Nordisk INC | $38.76 | 2021 | |
| Insulet Corporation | $17.73 | 2022 | |
| Amryt Pharma Holdings LTD | $16.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.